- Report
- March 2025
- 1048 Pages
Global
From €4198EUR$4,799USD£3,622GBP
- Report
- January 2026
- 192 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Drug Pipelines
- July 2025
- 280 Pages
Global
From €2624EUR$3,000USD£2,264GBP
- Report
- November 2025
- 183 Pages
Global
From €3936EUR$4,500USD£3,396GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1749EUR$2,000USD£1,509GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,287USD£3,126GBP
- Report
- January 2026
- 180 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1749EUR$2,000USD£1,509GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1749EUR$2,000USD£1,509GBP
- Report
- September 2025
- 950 Pages
Global
From €4369EUR$4,995USD£3,770GBP
- Report
- May 2025
- 472 Pages
Global
From €6118EUR$6,995USD£5,279GBP
- Report
- February 2026
- 281 Pages
Global
From €6118EUR$6,995USD£5,279GBP
- Report
- February 2026
- 262 Pages
Global
From €6118EUR$6,995USD£5,279GBP
- Report
- February 2026
- 388 Pages
Global
From €6118EUR$6,995USD£5,279GBP
- Report
- December 2025
- 391 Pages
Global
From €4198EUR$4,799USD£3,622GBP
- Report
- October 2025
- 598 Pages
Global
From €4198EUR$4,799USD£3,622GBP
- Report
- December 2025
- 678 Pages
Global
From €4198EUR$4,799USD£3,622GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more